A Study of IO Plus Radiotherapy in Patients With Advanced ESCC. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of IO Plus Radiotherapy in Patients With Advanced ESCC. — Stella

Recruiting

Back to Metastatic Esophageal Squamous Cell Carcinoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Fudan University Shanghai cancer center, Shanghai

Key details

Sponsor

Fudan University

Enrollment target

~100 participants

Started

February 2023

Primary completion

February 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Last updated July 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov